Pfizer to collaborate with Bertozzi start-up

Acepodia, a start-up developing cell therapies, is collaborating with Pfizer Ignite, which will offer research and development support for drug candidates targeting autoimmune diseases. Acepodia is also developing potential cancer drugs. The two companies did not disclose financial terms. Acepodia is a spinoff from the lab of Nobel laureate Carolyn Bertozzi and is building on her click chemistry work to create off-the-shelf cell therapies with few side effects.